Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State, Nigeria

View through CrossRef
Abstract Squamous cell carcinoma has been attributed to chronic schistosomiasis and is the predominant type of bladder cancer in schistosomiasis endemic areas. The aim of this study was to assess early promoter DNA methylation in selected genes implicated in schistosomiasis-associated bladder cancer (SABC). A total of 161 urine samples were collected from school aged children in Eggua Community of Ogun State and examined by microscopy for Schistosoma haematobium eggs. From this sample, a subset of 34(21.1%) urine samples positive for S. haematobium eggs and 22 formalin fixed paraffin-embedded bladder cancer tissues obtained from the University College Hospital Ibadan, were subjected to DNA isolation and bisulfite DNA conversion. Quantitative methylation specific PCR was used to determine the methylation status of APC, RARβ2, RASSF1A and TIMP3 in the samples. Methylation in APC, RARβ2, RASSF1A and TIMP3 was observed in 24(70.6%), 18(52.9%), 15(44.1%) and 8(23.5%) of the positive urine samples respectively and in 7(31.8%), 13(59.1%), 17(77.3%) and 8(36.4%) of bladder cancer tissues respectively. APC, RARβ2 and RASSF1A were 5-fold, 2-fold and 27-fold downregulated respectively in positive urine samples and 9-fold, 3-fold and 15-fold downregulated respectively in the bladder cancer tissues. The odds of promoter methylation in RARβ2 (OR: 1.133) were likely even with light infection. Gene promoter DNA methylation in tumour suppressor genes was observed in schistosomiasis cases. Hence, DNA methylation may occur during active Schistosoma haematobium in children. This result may serve as an early non-invasive biomarker to detect and hint at the risk of developing SABC later in life. Author summary Schistosoma haematobium can survive in the host for more than 20 years, during which time it causes damage to the bladder tissues and sometimes with no symptoms. Immune response to the parasite infection is inflammatory and leads to several morbidities like anaemia, undernutrition, dysuria, and female genital sores and may result in malignant transformation (schistosomiasis-associated bladder cancer) which presents in later years. Children are more susceptible to schistosomiasis because of having a naive immune system, making them targets for these morbidities, and including the possibility of developing bladder cancer in later years. DNA methylation which is often the first step in malignant transformation is known to be induced by inflammation during chronic schistosomiasis. Hence, assessing DNA methylation can serve as a biomarker for predicting the risk of developing bladder cancer later in life. In this study, we have established that DNA methylation occurs during childhood schistosomiasis and represents the time when events leading up to malignant transformation may begin. We suggest that once there is a schistosomiasis infection, DNA methylation will occur and unless the disease is treated on time, the individual is at risk of malignant transformation later in life.
Title: DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State, Nigeria
Description:
Abstract Squamous cell carcinoma has been attributed to chronic schistosomiasis and is the predominant type of bladder cancer in schistosomiasis endemic areas.
The aim of this study was to assess early promoter DNA methylation in selected genes implicated in schistosomiasis-associated bladder cancer (SABC).
A total of 161 urine samples were collected from school aged children in Eggua Community of Ogun State and examined by microscopy for Schistosoma haematobium eggs.
From this sample, a subset of 34(21.
1%) urine samples positive for S.
haematobium eggs and 22 formalin fixed paraffin-embedded bladder cancer tissues obtained from the University College Hospital Ibadan, were subjected to DNA isolation and bisulfite DNA conversion.
Quantitative methylation specific PCR was used to determine the methylation status of APC, RARβ2, RASSF1A and TIMP3 in the samples.
Methylation in APC, RARβ2, RASSF1A and TIMP3 was observed in 24(70.
6%), 18(52.
9%), 15(44.
1%) and 8(23.
5%) of the positive urine samples respectively and in 7(31.
8%), 13(59.
1%), 17(77.
3%) and 8(36.
4%) of bladder cancer tissues respectively.
APC, RARβ2 and RASSF1A were 5-fold, 2-fold and 27-fold downregulated respectively in positive urine samples and 9-fold, 3-fold and 15-fold downregulated respectively in the bladder cancer tissues.
The odds of promoter methylation in RARβ2 (OR: 1.
133) were likely even with light infection.
Gene promoter DNA methylation in tumour suppressor genes was observed in schistosomiasis cases.
Hence, DNA methylation may occur during active Schistosoma haematobium in children.
This result may serve as an early non-invasive biomarker to detect and hint at the risk of developing SABC later in life.
Author summary Schistosoma haematobium can survive in the host for more than 20 years, during which time it causes damage to the bladder tissues and sometimes with no symptoms.
Immune response to the parasite infection is inflammatory and leads to several morbidities like anaemia, undernutrition, dysuria, and female genital sores and may result in malignant transformation (schistosomiasis-associated bladder cancer) which presents in later years.
Children are more susceptible to schistosomiasis because of having a naive immune system, making them targets for these morbidities, and including the possibility of developing bladder cancer in later years.
DNA methylation which is often the first step in malignant transformation is known to be induced by inflammation during chronic schistosomiasis.
Hence, assessing DNA methylation can serve as a biomarker for predicting the risk of developing bladder cancer later in life.
In this study, we have established that DNA methylation occurs during childhood schistosomiasis and represents the time when events leading up to malignant transformation may begin.
We suggest that once there is a schistosomiasis infection, DNA methylation will occur and unless the disease is treated on time, the individual is at risk of malignant transformation later in life.

Related Results

Fluktuasi Schistosomiasis di Daerah Endemis Provinsi Sulawesi Tengah Tahun 2011-2018
Fluktuasi Schistosomiasis di Daerah Endemis Provinsi Sulawesi Tengah Tahun 2011-2018
Schistosomiasis is one of the most important parasitic diseases in public health . Schistosomiasis infected 230 million people in 77 countries and 600 million people are at risk. S...
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract 1289: Crosstalk between methylation and alternative splicing in cancer
Abstract Background: DNA methylation in promoter regions leads to transcriptional silencing, such as of tumor suppressor genes in cancer. However, the functions of D...
SALL4 Expression in Urothelial Carcinoma of Urinary Bladder; aTissue Microarray Analysis
SALL4 Expression in Urothelial Carcinoma of Urinary Bladder; aTissue Microarray Analysis
Sal-like protein 4 (SALL4) is a cellular pluripotent embryonic nuclear factor that has been a useful immunohistochemistry marker for germ-cell tumors. Our understanding of SALL4 ex...
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract A37: Aberrant DNA methylation of HTATIP2 and UCH-L1 as prognostic and predictive biomarkers for cholangiocarcinoma
Abstract Cholangiocarcinoma (CCA) is a malignancy of bile duct epithelial cell lining. In the past decade, the incidence and mortality rates of CCA have been increas...
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
AbstractSolute carrier family 12 member 5 (SLC12A5) has an oncogenic role in bladder urothelial carcinoma. The present study aimed to characterize the molecular mechanisms of SLC12...

Back to Top